See also this year's filing and all EDGAR filings for this company.
PDF Report 0001607678_2023_Viking_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001607678, Viking Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 167,040,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,489,000 |
| 4 | LiabilitiesCurrent | 21,947,000 |
| 5 | LiabilitiesNoncurrent | 1,260,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,121,000 |
| 9 | ResearchAndDevelopmentExpense | 54,234,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,488,000 |
| 13 | remainder_ComprehensiveNetIncome | -553,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 168,529,000 |
| 1 | Liabilities | 23,207,000 |
| 2 | Expenses | 70,355,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 145,322,000 |
| 5 | NetIncome | -68,867,000 |
| 6 | ComprehensiveNetIncome | -69,143,500 |
| 7 | BaseVar | 132,066,000 |
| 8 | EconomicCapitalRatio | 1.89 |
Edgar->Model Mapping
Feature Distribution
Change over Time
